Intranasal immunization with chlamydial protease-like activity factor and CpG deoxynucleotides enhances protective immunity against genital Chlamydia muridarum infection

This publication has 49 references indexed in Scilit:

• Intranasal Vaccination with a Secreted Chlamydial Protein Enhances Resolution of GenitalChlamydia muridarumInfection, Protects against Oviduct Pathology, and Is Highly Dependent upon Endogenous Gamma Interferon Production
  Infection and Immunity, 2007
• Chlamydial Protease-Like Activity Factor Induces Protective Immunity against Genital Chlamydial Infection in Transgenic Mice That Express the Human HLA-DR4 Allele
  Infection and Immunity, 2006
• The protective efficacy of chlamydial protease-like activity factor vaccination is dependent upon CD4+ T cells
  Cellular Immunology, 2006
• Inhibition of Proteolytic Activity of a Chlamydial Proteasome/Protease-Like Activity Factor by Antibodies from Humans Infected with Chlamydia trachomatis
  Infection and Immunity, 2005
• Production of a Proteolytically Active Protein, Chlamydial Protease/Proteasome-Like Activity Factor, by Five Different Chlamydia Species
  Infection and Immunity, 2005
• Human Antibody Responses to a Chlamydia-Secreted Protease Factor
  Infection and Immunity, 2004
• Chlamydia trachomatis pulmonary infection induces greater inflammatory pathology in immunoglobulin A deficient mice
  Cellular Immunology, 2004
• Immunization with the Chlamydia trachomatis Mouse Pneumonitis Major Outer Membrane Protein by Use of CpG Oligodeoxynucleotides as an Adjuvant Induces a Protective Immune Response against an Intranasal Chlamydial Challenge
  Infection and Immunity, 2002
• CpG Motifs in Bacterial DNA and Their Immune Effects
  Annual Review of Immunology, 2002
• New strategies for using mucosal vaccination to achieve more effective immunization
  Vaccine, 1994